Blair William & CO Rocket Pharmaceuticals, Inc. Transaction History

Blair William & CO

$33.4 Billion
Q3 2024

A detailed history of Blair William & CO transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Blair William & CO holds 134,969 shares of RCKT stock, worth $1.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

134,969

Previous 142,714 5.43%

Holding current value

$1.9 Million

Previous $3.07 Million 18.88%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$17.6 - $25.88 $136,312 - $200,440	-7,745 Reduced 5.43%	134,969 $2.49 Million
Q2 2024 Aug 12, 2024	SELL	$20.66 - $26.72 $94,333 - $122,003	-4,566 Reduced 3.1%	142,714 $3.07 Million
Q1 2024 May 09, 2024	BUY	$26.16 - $30.74 $10,490 - $12,326	401 Added 0.27%	147,280 $3.97 Million
Q4 2023 Feb 12, 2024	SELL	$16.78 - $31.94 $48,829 - $92,945	-2,910 Reduced 1.94%	146,879 $4.4 Million
Q3 2023 Nov 09, 2023	BUY	$15.07 - $24.05 $2.26 Million - $3.6 Million	149,789 New	149,789 $3.07 Million
Q3 2022 Nov 09, 2022	SELL	$12.37 - $18.41 $16,080 - $23,933	-1,300 Reduced 10.21%	11,431 $182,000
Q2 2022 Aug 10, 2022	BUY	$7.96 - $16.64 $1,432 - $2,995	180 Added 1.43%	12,731 $175,000
Q1 2022 May 13, 2022	BUY	$13.16 - $23.68 $5,264 - $9,472	400 Added 3.29%	12,551 $199,000
Q4 2021 Feb 14, 2022	SELL	$21.52 - $36.02 $2,152 - $3,602	-100 Reduced 0.82%	12,151 $265,000
Q3 2021 Nov 12, 2021	SELL	$27.42 - $48.97 $9,597 - $17,139	-350 Reduced 2.78%	12,251 $366,000
Q2 2021 Aug 12, 2021	SELL	$39.41 - $47.25 $75,076 - $90,011	-1,905 Reduced 13.13%	12,601 $558,000
Q1 2021 May 13, 2021	SELL	$43.34 - $65.91 $175,960 - $267,594	-4,060 Reduced 21.87%	14,506 $644,000
Q4 2020 Feb 09, 2021	SELL	$23.3 - $59.57 $476,205 - $1.22 Million	-20,438 Reduced 52.4%	18,566 $1.02 Million
Q3 2020 Nov 06, 2020	BUY	$20.5 - $28.59 $4,530 - $6,318	221 Added 0.57%	39,004 $892,000
Q2 2020 Aug 12, 2020	BUY	$13.32 - $22.61 $50,496 - $85,714	3,791 Added 10.83%	38,783 $812,000
Q1 2020 May 11, 2020	SELL	$9.71 - $25.11 $504,580 - $1.3 Million	-51,965 Reduced 59.76%	34,992 $488,000
Q4 2019 Feb 13, 2020	BUY	$11.07 - $24.23 $962,613 - $2.11 Million	86,957 New	86,957 $1.98 Million

Others Institutions Holding RCKT

# of Institutions

209

Shares Held

93.2M

Call Options Held

319K

Put Options Held

70.3K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.07B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account